# Intra-Cellular Therapies, Inc. — Form D

Intra-Cellular Therapies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-11. The offering totals $70.3M, of which $70.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-09-11
- Form: D
- Accession: 0001176407-13-000006
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $70.3M
- Amount sold: $70.3M
- Investors: 274
- Date of first sale: 2013-08-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-202688

## Issuer

- Name: Intra-Cellular Therapies, Inc.
- CIK: 0001567514
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 3960 BROADWAY, NEW YORK, NY, 10032
- Phone: 212-923-3344

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Allen Fienberg | Director | New York, NY |
| Sharon Mates | Director | New York, NY |
| Samir Nasri | Director | Great Neck, NY |
| Lawrence Hineline | Executive Officer | New York, NY |
| Sharon Mates | Executive Officer | New York, NY |
| Kimberly Vanover | Executive Officer | New York, NY |
| Lawrence Wennogle | Executive Officer | New York, NY |

## More

- [CIK 1567514 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1567514&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001176407-13-000006.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.